## **Core Concept**
The question pertains to the management of a patient with a combination of type 2 diabetes mellitus (DM), hypertension (HTN), and obesity. The ideal drug for such a patient should have a beneficial or neutral effect on these conditions.

## **Why the Correct Answer is Right**
Metformin is the correct answer because it is a first-line medication for type 2 diabetes that has a favorable effect on weight and does not exacerbate hypertension. It works by decreasing glucose production in the liver, improving insulin sensitivity, and facilitating glucose uptake into muscles. Additionally, metformin has been shown to have a neutral or slightly beneficial effect on blood pressure and body weight, making it an ideal choice for patients with comorbid obesity and hypertension.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Sulfonylureas can cause weight gain and increase the risk of hypoglycemia, making them less ideal for patients with obesity.
- **Option B:** Thiazolidinediones can cause fluid retention, leading to worsening hypertension and potential heart failure, and are also associated with weight gain.
- **Option D:** Insulin can cause weight gain, although it is sometimes necessary for managing diabetes. However, as a first-line agent for a patient with DM, HTN, and obesity, it is not the preferred initial choice.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that metformin is often considered a cornerstone in the management of type 2 diabetes, especially in patients with comorbidities like obesity and hypertension, due to its benefits on weight and cardiovascular risk factors.

## **Correct Answer:** C. Metformin.